Back to Search
Start Over
P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study.
- Source :
- Breast; 2023 Supplement, Vol. 68, pS63-S64, 2p
- Publication Year :
- 2023
- Subjects :
- PEMBROLIZUMAB
PLACEBOS
CANCER chemotherapy
Subjects
Details
- Language :
- English
- ISSN :
- 09609776
- Volume :
- 68
- Database :
- Supplemental Index
- Journal :
- Breast
- Publication Type :
- Academic Journal
- Accession number :
- 162439806
- Full Text :
- https://doi.org/10.1016/S0960-9776(23)00242-4